Amedisys Inc
NASDAQ:AMED

Watchlist Manager
Amedisys Inc Logo
Amedisys Inc
NASDAQ:AMED
Watchlist
Price: 100.99 USD 0.01% Market Closed
Market Cap: $3.3B

Wall St Price Targets

AMED Price Targets Summary
Amedisys Inc

There are no price targets for AMED.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Amedisys Inc Competitors:
Price Targets
VNET
Vianet Group PLC
235% Upside
TNDM
Tandem Diabetes Care Inc
101% Upside
APO
Apollo Global Management Inc
15% Upside

Revenue
Forecast

4% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
4% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 6%.

Operating Income
Forecast

5% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
5% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 12%.

Net Income
Forecast

N/A
Past Growth
58% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss
N/A
Past Growth
58% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss

The compound annual growth rate for Net Income over the next 3 years is 58%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AMED's stock price target?
Not Available

AMED does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Amedisys Inc?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 6%.

What is the Operating Income forecast for Amedisys Inc?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 12%.

What is the Net Income forecast for Amedisys Inc?
Projected CAGR
58%

The compound annual growth rate for Net Income over the next 3 years is 58%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett